Burney Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-92,840
Closed -$9.22M 474
2019
Q3
$9.22M Buy
92,840
+12,389
+15% +$1.18M 0.55% 56
2019
Q2
$7.44M Sell
80,451
-11,870
-13% -$1.13M 0.45% 72
2019
Q1
$8.71M Buy
92,321
+46,099
+100% +$4.03M 0.54% 50
2018
Q4
$2.96M Buy
46,222
+33,186
+255% +$2.45M 0.21% 141
2018
Q3
$1.17M Sell
13,036
-868
-6% -$76.7K 0.07% 244
2018
Q2
$1.1M Buy
13,904
+6,081
+78% +$505K 0.06% 239
2018
Q1
$698K Sell
7,823
-13,859
-64% -$1.33M 0.04% 266
2017
Q4
$2.26M Sell
21,682
-1,161
-5% -$131K 0.13% 177
2017
Q3
$3.26M Buy
22,843
+356
+2% +$48.5K 0.21% 136
2017
Q2
$2.96M Buy
22,487
+100
+0.4% +$12.3K 0.19% 132
2017
Q1
$2.79M Sell
22,387
-135
-0.6% -$16.2K 0.18% 138
2016
Q4
$2.61M Sell
22,522
-1,784
-7% -$199K 0.18% 140
2016
Q3
$2.57M Buy
24,306
+380
+2% +$41.1K 0.18% 135
2016
Q2
$2.36M Buy
23,926
+550
+2% +$56.9K 0.17% 138
2016
Q1
$2.34M Sell
23,376
-280
-1% -$28.8K 0.17% 140
2015
Q4
$2.82M Sell
23,656
-3,050
-11% -$353K 0.21% 125
2015
Q3
$2.89M Sell
26,706
-691
-3% -$85.8K 0.22% 121
2015
Q2
$3.17M Buy
27,397
+22,235
+431% +$2.54M 0.22% 120
2015
Q1
$595K Sell
5,162
-23,345
-82% -$2.79M 0.04% 262
2014
Q4
$3.19M Sell
28,507
-255
-0.9% -$26.9K 0.25% 116
2014
Q3
$2.73M Buy
28,762
+2,917
+11% +$263K 0.23% 115
2014
Q2
$2.22M Sell
25,845
-1,737
-6% -$132K 0.19% 135
2014
Q1
$1.93M Sell
27,582
-908
-3% -$71.9K 0.18% 139
2013
Q4
$2.41M Sell
28,490
-1,300
-4% -$103K 0.23% 121
2013
Q3
$2.3M Sell
29,790
-3,714
-11% -$260K 0.26% 110
2013
Q2
$1.96M Buy
+33,504
New +$2.02M 0.24% 119

Other funds holding CELG

Burney Company's CELG Position: Q4 2019 in Review

Burney Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 92,840 shares — an estimated $9.22M sold.

Burney Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $9.22M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Burney Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Burney Company sold 92,840 Celgene Corp shares in Q4 2019, an estimated $9.22M.
  • Burney Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Burney Company's Celgene Corp position peaked at $9.22M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Burney Company's 13F filing for Q4 2019, filed 14 Feb 2020.